The Role of a Pharmacist in Breaking Down Barriers to Improve Continuous Glucose Monitoring Use
by Erin Newkirk, PharmD, CDCES, BCPS, Sushma Dey, PharmD
"Continuous glucose monitoring (CGM) systems are wearable devices that are inserted into the skin to measure interstitial glucose levels every 1-5 minutes throughout the day. CGM allows patients and clinicians to view glucose data trends, and the majority of systems are approved by the U.S. Food and Drug Administration (FDA) to be used for diabetes treatment decision making (Table 1). CGM use has been increasing and can be beneficial for patients who require selfmonitoring of glucose. CGM systems can be prescribed for personal and professional use. “Personal” use refers to prescribing a CGM for the patient to use and view the transmitted data. The two types of personal CGMs on the market are realtime CGMs (rtCGMs) and intermittently scanned CGMs (isCGMs).1 The major difference between the two is that rtCGMs automatically transmit a continuous stream of glucose data to a receiver, while isCGMs require the patient to scan the sensor to obtain glucose information."
Keywords: Insulin, Insulin, Short-Acting, Blood Glucose Self-Monitoring, Glucose, Patient Selection, Pharmacists, United States Food and Drug Administration, Hypoglycemia, Insulin, Regular, Human, Diabetes Complications, Wearable, Electronic Devices, Decision Making, Reference Standards
Download PDF
2021 July/August Table of Contents
"Continuous glucose monitoring (CGM) systems are wearable devices that are inserted into the skin to measure interstitial glucose levels every 1-5 minutes throughout the day. CGM allows patients and clinicians to view glucose data trends, and the majority of systems are approved by the U.S. Food and Drug Administration (FDA) to be used for diabetes treatment decision making (Table 1). CGM use has been increasing and can be beneficial for patients who require selfmonitoring of glucose. CGM systems can be prescribed for personal and professional use. “Personal” use refers to prescribing a CGM for the patient to use and view the transmitted data. The two types of personal CGMs on the market are realtime CGMs (rtCGMs) and intermittently scanned CGMs (isCGMs).1 The major difference between the two is that rtCGMs automatically transmit a continuous stream of glucose data to a receiver, while isCGMs require the patient to scan the sensor to obtain glucose information."
Keywords: Insulin, Insulin, Short-Acting, Blood Glucose Self-Monitoring, Glucose, Patient Selection, Pharmacists, United States Food and Drug Administration, Hypoglycemia, Insulin, Regular, Human, Diabetes Complications, Wearable, Electronic Devices, Decision Making, Reference Standards
Download PDF
2021 July/August Table of Contents